Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD137 antibodies and PD-1 antagonists and uses thereof

CD137 antibodies and PD-1 antagonists and uses thereof

US Patent 11718679 · Granted Aug 8, 2023

Estimated economic value: $5,582,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multispecific binding constructs against checkpoint molecules and uses thereof2025
Method of treating cancer using CD137 antibodies and PD-1 antagonists2025
Method of treating cancer using CD137 antibodies and PD-1 antagonists2025
Tumor-specific cleavable linkers2025
Multispecific binding constructs against checkpoint molecules and uses thereof2024
CD137 antibodies and tumor antigen-targeting antibodies and uses thereof2023
CD137 antibodies and tumor antigen-targeting antibodies and uses thereof2023
Agonist antibodies that bind human CD137 and uses thereof2023
Agonist antibodies that bind human CD137 and uses thereof2023
Multispecific binding constructs against checkpoint molecules and uses thereof2021
Agonist antibodies that bind human CD137 and uses thereof2020
Agonist antibodies that bind human CD137 and uses thereof2020